FANCC: A Potential Drug Target and Biomarker for Cancer and Other Diseases

Target Name: FANCC

NCBI ID: G2176

FANCC

FANCC: A Potential Drug Target and Biomarker for Cancer and Other Diseases

FANCC (FANCC variant 1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. FANCC is a non-coding RNA molecule that has been shown to play a role in the regulation of cell growth and differentiation.

Studies have shown that FANCC is expressed in a wide range of tissues and cells, including the brain, pancreas, and gastrointestinal tract. It has also been shown to be involved in the regulation of cell proliferation, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels).

One of the key features of FANCC is its ability to interact with a variety of protein molecules, including the transcription factor PDGF-BB. This interaction has been shown to play a role in the regulation of cell growth, differentiation, and survival.

In addition to its role in cell biology, FANCC has also been shown to be involved in the regulation of inflammation and immune responses. This has led some researchers to consider FANCC as a potential drug target for the treatment of autoimmune diseases.

FANCC has also been shown to be involved in the regulation of cell migration and the development of cancer. This has led some researchers to consider FANCC as a potential drug target for the treatment of cancer.

FANCC is also a potential biomarker for several diseases, including cancer. This is because it has been shown to be expressed in the cells that are most likely to be responsible for the development and progression of these diseases. For example, FANCC has been shown to be expressed in the cells of breast cancer tumors, and it has been shown to be involved in the regulation of cell growth and apoptosis in these tumors.

In conclusion, FANCC is a gene that has been shown to play a role in the regulation of cell growth and differentiation, as well as in the regulation of cell proliferation, apoptosis, and angiogenesis. It has also been shown to interact with a variety of protein molecules, including the transcription factor PDGF-BB, and to be involved in the regulation of cell biology, inflammation, and immune responses. In addition, FANCC has also been shown to be involved in the regulation of cell migration and the development of cancer, and it has been identified as a potential drug target and biomarker for these diseases. Further research is needed to fully understand the role of FANCC in these processes and to determine its potential as a drug.

Protein Name: FA Complementation Group C

Functions: DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. Upon IFNG induction, may facilitate STAT1 activation by recruiting STAT1 to IFNGR1

The "FANCC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FANCC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets